·
2 Min Read

AMA statement on HHS decision to remove barriers for opioid treatment

AMA strongly endorses today’s decision by HHS to allow physicians to prescribe without a waiver highly effective medication for opioid use disorder.

Press Releases
AMA Research Challenge collage
·
4 Min Read

Research on ventilator allocation, e-cigarettes lands top honors

Beating out nearly 1,000 other research entries, two medical students share the top prize in the first-ever AMA Research Challenge.

Publishing Research
Pharmacy
·
4 Min Read

U.S. Supreme Court: State law can require PBMs to pay fair amount

Physicians asked high court to uphold a state PBM drug-pricing law protecting access to independent and rural pharmacies, and the justices agreed.

Judicial Advocacy
·
3 Min Read

Jan. 8, 2021: State Advocacy Update

Coverage for all forms of MOUD now required by Medicaid and more in the latest State Advocacy Update.

Advocacy Update
·
2 Min Read

Jan. 8, 2021: Judicial Advocacy Update

Courts block Jan. 1 implementation of most favored nations drug pricing model in the latest judicial Advocacy Update.

Advocacy Update
Physician wearing a face mask
·
3 Min Read

Georgia public-private partners seek statewide SUD treatment network

Having local evidence-based treatment for substance-use disorder throughout the state of Georgia is a goal of Emory-Hazelden Betty Ford partnership.

Behavioral Health
Shamsh Shaikh
·
4 Min Read

Q&A with Research Challenge finalist Shamsh Shaikh

The epidemic of e-cigarette use inspired Shamsh Shaikh to conduct research that resulted in a place in the AMA Research Challenge.

series
Research
Succeeding in Medical School
Close-up of a physician using a smart tablet.
·
5 Min Read

Collaborative care model for mental health, addiction treatment

The physician architects of a Penn Medicine model of integrated physical and mental health care detail its success.

Behavioral Health
·
4 Min Read

Policy road map shows the way to end the overdose epidemic

It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.

Behavioral Health